Search

everythinglearnresearchcommunity

for

Search:↓

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

New treatments aim to improve thin endometrium to help more couples with infertility.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

High doses of finasteride cause cell growth and tumors in mice.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Menopause affects hair and skin; more research needed for treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Minoxidil helps prevent stress-caused hair loss in mice.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Low prolactin in young women may increase heart and metabolism risks.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.